Page last updated: 2024-10-28

guanethidine and EHS Tumor

guanethidine has been researched along with EHS Tumor in 2 studies

Guanethidine: An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues.
guanethidine : A member of the class of guanidines in which one of the hydrogens of the amino group has been replaced by a 2-azocan-1-ylethyl group.
guanethidine sulfate : A organic sulfate salt composed of two molecules of guanethidine and one of sulfuric acid.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tereshchenko, IP1
Kashulina, AP1
Sobieva, ZI1
Aleksandrova, LM1
Boeryd, B1
Hagmar, B1
Johnsson, G1
Ryd, W1

Other Studies

2 other studies available for guanethidine and EHS Tumor

ArticleYear
[New informative index of the functional status of polymorphonuclear neutrophils].
    Biulleten' eksperimental'noi biologii i meditsiny, 1984, Volume: 98, Issue:10

    Topics: Animals; Biophysical Phenomena; Biophysics; Epinephrine; Guanethidine; Hypertonic Solutions; Methods

1984
Effects of EACA, AMCHA and guanethidine on metastases induced by intravenously injected tumour cells.
    Pathologia Europaea, 1974, Volume: 9, Issue:2

    Topics: Aminocaproates; Animals; Antifibrinolytic Agents; Cyclohexanecarboxylic Acids; Guanethidine; Injecti

1974